Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Long-term survival after breast cancer diagnosis

02.06.2003


Most breast cancer patients with more than 10 nodes that are affected by the cancer have a poor prognosis, yet some survive long-term. Physicians now believe that certain genes in the breast cancer tissue, removed at diagnosis, can help them predict which patients will survive.



With this information, doctors can recommend the most appropriate therapy for an individual patient, for example sparing a woman with a poor prognosis the rigors that accompany aggressive chemotherapy, and enabling her to receive novel treatments that might work, according to Dr. Melody Cobleigh, oncologist, professor of medicine and director of the Comprehensive Breast Center at Rush-Presbyterian-St. Luke’s Medical Center in Chicago.

Cobleigh presented her research results on May 31 at the American Society of Clinical Oncology Annual Meeting in Chicago. Until now, such studies could only be performed on recently biopsied tissue that would then be frozen for preservation. Routine handling of cancer specimens does not involve freezing. Cobleigh and colleagues at Genomic Health examined the breast cancer tissue of 79 patients who had been treated at Rush between 1979 and 1999 and whose tissues had been processed in the usual manner (formalin-fixed and paraffin-embedded). The patients had been followed for a median of 15 years.


Expression of 185 cancer-related genes was assessed. The genes chosen were based on previous reports on frozen tissues. Cobleigh determined that those women whose tumors expressed excess amounts of some genes, e.g. TP53BP2, PR and Bcl2, were more likely to be free of cancer in their vital organs. She also found that women whose tumors expressed too much of other genes, e.g. GRB7, CTSL and DIABLO experienced a worse outcome. Cobleigh reported that even among women with 10 or more positive nodes, the gene expression profile could predict long-term survival.

"Until now, the only indications we have had of long-term prognosis were tumor size and the number of involved nodes," Cobleigh said. "This technology will allow us to tailor a prognosis to the individual patient, using information from thousands of genes."

She cautioned, however, that her research is a first step. "These findings must be confirmed in independent data sets," she said. She pointed out, however, that this is already underway, using material from tumor banks owned and managed by international cooperative groups, such as the National Surgical Adjuvant Breast and Bowel Project (NSABP), which is a clinical trials cooperative group supported by the National Cancer Institute (NCI). If results are validated, the test could become commercially available within a year.

Cobleigh, who was an investigator in the 1990s on the clinical trials to test the monoclonal antibody Herceptin, suggested that another offshoot of this work is to examine the tumor for expression of genes that will predict responsiveness to specific therapies, such as Herceptin.

Tumor tissue for this research was generated from the Bill Shorey Database of Breast Tumors, named after Dr. Bill Shorey, a breast surgeon who worked at Rush for more than 30 years. The Shorey Database was computerized by Dr. David Roseman, another surgeon who worked at Rush for over 30 years, and Michigan physician Dr. Craig Silverton.


Rush-Presbyterian-St. Luke’s Medical Center includes the 824-bed Presbyterian-St. Luke’s Hospital; 110-bed Johnston R. Bowman Health Center; Rush University (Rush Medical College, College of Nursing, College of Health Sciences and the Graduate College).

Chris Martin | EurekAlert!
Further information:
http://www.rush.edu/

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>